---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-049491"
form_type: "8-K/A"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:04:09.476918+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma accepts additional $670K in Reg S offering, issuing 957,144 shares

## Summary
- Initial Reg S offering (Apr 30–May 9) sold 1,030,413 shares for aggregate gross proceeds ~$619,625.
- On May 27, accepted additional subscriptions of $670,000 for 957,144 shares on same terms as initial offering.
- All shares sold to non-U.S. persons under Regulation S; voting rights transferred to chairman Eugene Jiang.
- Combined gross proceeds from both tranches total ~$1.29 million; shares unregistered for one year.

## SEC filing metadata
- accession: 0001213900-25-049491
- form_type: 8-K/A
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390025049491/0001213900-25-049491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390025049491/ea0243649-8ka_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-049491
- JSON: https://secwatch.observer/filing/0001213900-25-049491.json
- Plain text: https://secwatch.observer/filing/0001213900-25-049491.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.